Department of Pharmacology, Box 357280, University of Washington, Seattle, WA, USA; Howard Hughes Medical Institute, University of Washington, Seattle, WA, USA.
Department of Pharmacology, Box 357280, University of Washington, Seattle, WA, USA; Howard Hughes Medical Institute, University of Washington, Seattle, WA, USA.
Curr Opin Struct Biol. 2024 Jun;86:102811. doi: 10.1016/j.sbi.2024.102811. Epub 2024 Apr 9.
Molecular glue (MG) degraders are monovalent small molecule compounds that co-opt E3 ubiquitin ligases to target neo-substrates for proteasomal degradation. Here, we provide a concise review of recent advances in rational MG discovery, which are categorized into two major strategies, ligand modification and de novo discovery. We also highlight the structural mechanisms underlying the formation of MG-enabled ternary complexes and their thermodynamic properties. Finally, we summarize the broader category of proximity inducers including MGs, proteolysis-targeting chimeras (PROTACs), peptides, and viral proteins. MGs are specified as a unique class of proximity inducers with chemical simplicity and a requirement of pre-existing weak protein-protein interactions. We propose that leveraging the weak basal interaction provides a starting point to prospectively develop MGs to degrade high-value therapeutic targets.
分子胶 (MG) 降解剂是单价小分子化合物,可利用 E3 泛素连接酶将新底物靶向蛋白酶体降解。在这里,我们提供了对合理 MG 发现的最新进展的简明回顾,这些进展分为两种主要策略,配体修饰和从头发现。我们还强调了形成 MG 使能三元复合物的结构机制及其热力学特性。最后,我们总结了更广泛的邻近诱导物类别,包括 MG、蛋白水解靶向嵌合体 (PROTAC)、肽和病毒蛋白。MG 被指定为具有化学简单性和对预先存在的弱蛋白-蛋白相互作用的要求的独特类别的邻近诱导物。我们提出,利用弱的基础相互作用为有前景地开发 MG 以降解高价值的治疗靶标提供了一个起点。